Literature DB >> 16790767

Cloning, characterization, and serodiagnostic evaluation of Leishmania infantum tandem repeat proteins.

Yasuyuki Goto1, Rhea N Coler, Jeffrey Guderian, Raodoh Mohamath, Steven G Reed.   

Abstract

Visceral leishmaniasis (VL) is a form of leishmaniasis, which is caused by infection with the protozoan parasite Leishmania, and is often fatal unless it is treated. Rapid and accurate diagnosis of VL is important for effective treatment. Here we report the cloning of previously undescribed tandem repeat (TR) proteins of Leishmania infantum and an evaluation of VL patient antibody responses to the corresponding proteins. By screening an L. infantum expression library with sera from human VL patients or infected hamsters, we identified 43 genes encoding B-cell antigens. Surprisingly, 19 of the 43 genes (44%) were TR proteins, and that percentage was significantly higher than that for genes picked randomly from the database. We then expressed the TR regions of LinJ16.1750, LinJ22.1590, and LinJ33.2870 and the entire LinJ28.2310 protein. These recombinant proteins were all recognized by Sudanese VL patient sera in an enzyme-linked immunosorbent assay. Recombinant LinJ16.1750 (rLinJ16.1750) showed the best performance among these antigens in terms of both sensitivity and specificity. Serological evaluation revealed that 97% (34 of 35) of Sudanese VL patients had significantly elevated antibody levels to rLinJ16.1750. Furthermore, when eight of the patient sera which had low reactivities to rK39 were tested with the novel recombinant antigens, some of the sera showed stronger antibody responses to these antigens than to rK39. Our results suggest that TR regions from the novel L. infantum proteins identified in this study are immunodominant B-cell epitopes and may represent good candidates for serodiagnosis of VL.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16790767      PMCID: PMC1489730          DOI: 10.1128/IAI.00101-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  28 in total

1.  Diagnosing visceral leishmaniasis with the recombinant K39 strip test: experience from the Sudan.

Authors:  E E Zijlstra; Y Nur; P Desjeux; E A Khalil; A M El-Hassan; J Groen
Journal:  Trop Med Int Health       Date:  2001-02       Impact factor: 2.622

2.  Immunochromatographic strip-test detection of anti-K39 antibody in Indian visceral leishmaniasis.

Authors:  S Sundar; K Pai; M Sahu; V Kumar; H W Murray
Journal:  Ann Trop Med Parasitol       Date:  2002-01

3.  Use of the recombinant K39 dipstick test and the direct agglutination test in a setting endemic for visceral leishmaniasis in Nepal.

Authors:  C Bern; S N Jha; A B Joshi; G D Thakur; M B Bista
Journal:  Am J Trop Med Hyg       Date:  2000 Sep-Oct       Impact factor: 2.345

4.  Comparative evaluation of ELISAs based on ten recombinant or purified Leishmania antigens for the serodiagnosis of Mediterranean visceral leishmaniasis.

Authors:  Ibtissem Abdmouleh Maalej; Mehdi Chenik; Hechmi Louzir; Afif Ben Salah; Chokri Bahloul; Fethi Amri; Koussay Dellagi
Journal:  Am J Trop Med Hyg       Date:  2003-03       Impact factor: 2.345

5.  Rapid accurate field diagnosis of Indian visceral leishmaniasis.

Authors:  S Sundar; S G Reed; V P Singh; P C Kumar; H W Murray
Journal:  Lancet       Date:  1998-02-21       Impact factor: 79.321

6.  An enzyme-linked immunosorbent assay (ELISA) for field diagnosis of visceral leishmaniasis.

Authors:  M Ho; J Leeuwenburg; G Mbugua; A Wamachi; A Voller
Journal:  Am J Trop Med Hyg       Date:  1983-09       Impact factor: 2.345

Review 7.  Recent advances in the diagnosis of leishmaniasis.

Authors:  S Singh; R Sivakumar
Journal:  J Postgrad Med       Date:  2003 Jan-Mar       Impact factor: 1.476

8.  Molecular characterization of the Leishmania braziliensis L6 ribosomal protein.

Authors:  M C Thomas; E Martinez-Carretero; E Carmelo; A C González; B Valladares
Journal:  J Parasitol       Date:  2004-08       Impact factor: 1.276

9.  Expression cloning.

Authors:  Michael J Lodes; Davin C Dillon; Raymond L Houghton; Yasir A W Skeiky
Journal:  Methods Mol Med       Date:  2004

10.  Immunofluorescent antibody test in American visceral leishmaniasis: sensitivity and specificity of different morphological forms of two Leishmania species.

Authors:  R Badaró; S G Reed; E M Carvalho
Journal:  Am J Trop Med Hyg       Date:  1983-05       Impact factor: 2.345

View more
  23 in total

1.  Characterization of novel Leishmania infantum recombinant proteins encoded by genes from five families with distinct capacities for serodiagnosis of canine and human visceral leishmaniasis.

Authors:  Geraldo G S Oliveira; Franklin B Magalhães; Márcia C A Teixeira; Andrea M Pereira; Cristiane G M Pinheiro; Lenita R Santos; Marília B Nascimento; Cheila N G Bedor; Alessandra L Albuquerque; Washington L C dos-Santos; Yara M Gomes; Edson D Moreira; Maria E F Brito; Lain C Pontes de Carvalho; Osvaldo P de Melo Neto
Journal:  Am J Trop Med Hyg       Date:  2011-12       Impact factor: 2.345

2.  Elevation of serum B-cell activating factor levels during visceral leishmaniasis.

Authors:  Yasuyuki Goto; Satoko Omachi; Chizu Sanjoba; Yoshitsugu Matsumoto
Journal:  Am J Trop Med Hyg       Date:  2014-08-25       Impact factor: 2.345

3.  Protective immunization against visceral leishmaniasis using Leishmania sterol 24-c-methyltransferase formulated in adjuvant.

Authors:  Yasuyuki Goto; Lisa Y Bogatzki; Sylvie Bertholet; Rhea N Coler; Steven G Reed
Journal:  Vaccine       Date:  2007-08-20       Impact factor: 3.641

4.  The Leishmania infantum PUF proteins are targets of the humoral response during visceral leishmaniasis.

Authors:  Cristina Folgueira; Marta Martínez-Bonet; Jose M Requena
Journal:  BMC Res Notes       Date:  2010-01-21

5.  Specific antibody responses as indicators of treatment efficacy for visceral leishmaniasis.

Authors:  A C Vallur; A Hailu; D Mondal; C Reinhart; H Wondimu; Y Tutterrow; H W Ghalib; S G Reed; M S Duthie
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-11-19       Impact factor: 3.267

6.  Transmembrane molecules for phylogenetic analyses of pathogenic protists: Leishmania-specific informative sites in hydrophilic loops of trans- endoplasmic reticulum N-acetylglucosamine-1-phosphate transferase.

Authors:  Kayoko Waki; Sujoy Dutta; Debalina Ray; Bala Krishna Kolli; Leyla Akman; Shin-Ichiro Kawazu; Chung-Ping Lin; Kwang-Poo Chang
Journal:  Eukaryot Cell       Date:  2006-12-01

Review 7.  The development and clinical evaluation of second-generation leishmaniasis vaccines.

Authors:  Malcolm S Duthie; Vanitha S Raman; Franco M Piazza; Steven G Reed
Journal:  Vaccine       Date:  2011-11-12       Impact factor: 3.641

8.  Design, development and evaluation of rK28-based point-of-care tests for improving rapid diagnosis of visceral leishmaniasis.

Authors:  Sowmya Pattabhi; Jacqueline Whittle; Raodoh Mohamath; Sayda El-Safi; Garner G Moulton; Jeffrey A Guderian; Danny Colombara; Asem O Abdoon; Maowia M Mukhtar; Dinesh Mondal; Javan Esfandiari; Shailendra Kumar; Peter Chun; Steven G Reed; Ajay Bhatia
Journal:  PLoS Negl Trop Dis       Date:  2010-09-14

9.  Immunological dominance of Trypanosoma cruzi tandem repeat proteins.

Authors:  Yasuyuki Goto; Darrick Carter; Steven G Reed
Journal:  Infect Immun       Date:  2008-07-14       Impact factor: 3.441

10.  Identification of a highly antigenic region of subtilisin-like serine protease 1 for serodiagnosis of Neospora caninum infection.

Authors:  Rochelle Haidee D Ybañez; Mohamad Alaa Terkawi; Kyohko Kameyama; Xuenan Xuan; Yoshifumi Nishikawa
Journal:  Clin Vaccine Immunol       Date:  2013-08-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.